VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Tóm tắt
Từ khóa
Tài liệu tham khảo
Altschul, 1990, Basic local alignment search tool, J. Mol. Biol., 215, 403, 10.1016/S0022-2836(05)80360-2
Ansari, 2003, The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice, J. Exp. Med., 198, 63, 10.1084/jem.20022125
Atkinson, 2009, Using sequence similarity networks for visualization of relationships across diverse protein superfamilies, PLoS ONE., 4, e4345, 10.1371/journal.pone.0004345
Blank, 2004, PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells, Cancer Res., 64, 1140, 10.1158/0008-5472.CAN-03-3259
Blank, 2005, Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy, Cancer Immunol. Immunother., 54, 307, 10.1007/s00262-004-0593-x
Borriello, 1997, B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation, Immunity., 6, 303, 10.1016/S1074-7613(00)80333-7
Brandt, 2009, The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans, J. Exp. Med., 206, 1495, 10.1084/jem.20090681
Breithaupt, 2003, Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein, Proc. Natl. Acad. Sci. USA., 100, 9446, 10.1073/pnas.1133443100
Butte, 2007, Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses, Immunity., 27, 111, 10.1016/j.immuni.2007.05.016
Carter, 2002, PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2, Eur. J. Immunol., 32, 634, 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
Chambers, 1997, Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells, Immunity., 7, 885, 10.1016/S1074-7613(00)80406-9
Dong, 2001, ICOS co-stimulatory receptor is essential for T-cell activation and function, Nature., 409, 97, 10.1038/35051100
Dong, 2003, B7-H1 pathway and its role in the evasion of tumor immunity, J. Mol. Med., 81, 281, 10.1007/s00109-003-0430-2
Dong, 2002, Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nat. Med., 8, 793, 10.1038/nm730
Fontenot, 2005, Regulatory T cell lineage specification by the forkhead transcription factor foxp3, Immunity., 22, 329, 10.1016/j.immuni.2005.01.016
Geng, 2006, HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma, Int. J. Cancer., 118, 2657, 10.1002/ijc.21795
Gouet, 1999, ESPript: analysis of multiple sequence alignments in PostScript, Bioinformatics., 15, 305, 10.1093/bioinformatics/15.4.305
Grabie, 2007, Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart, Circulation., 116, 2062, 10.1161/CIRCULATIONAHA.107.709360
Greenwald, 2005, The B7 family revisited, Annu. Rev. Immunol., 23, 515, 10.1146/annurev.immunol.23.021704.115611
Guleria, 2005, A critical role for the programmed death ligand 1 in fetomaternal tolerance, J. Exp. Med., 202, 231, 10.1084/jem.20050019
Hernández Prada, 2006, Ancient evolutionary origin of diversified variable regions demonstrated by crystal structures of an immune-type receptor in amphioxus, Nat. Immunol., 7, 875, 10.1038/ni1359
Hollenbaugh, 1995, Cleavable CD40Ig fusion proteins and the binding to sgp39, J. Immunol. Methods., 188, 1, 10.1016/0022-1759(95)00194-8
Holm, 2000, DaliLite workbench for protein structure comparison, Bioinformatics., 16, 566, 10.1093/bioinformatics/16.6.566
Iwai, 2002, Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade, Proc. Natl. Acad. Sci. USA., 99, 12293, 10.1073/pnas.192461099
Keir, 2006, Tissue expression of PD-L1 mediates peripheral T cell tolerance, J. Exp. Med., 203, 883, 10.1084/jem.20051776
Keir, 2007, PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues, J. Immunol., 179, 5064, 10.4049/jimmunol.179.8.5064
Keir, 2008, PD-1 and its ligands in tolerance and immunity, Annu. Rev. Immunol., 26, 677, 10.1146/annurev.immunol.26.021607.090331
Larkin, 2007, Clustal W and Clustal X version 2.0, Bioinformatics., 23, 2947, 10.1093/bioinformatics/btm404
Latchman, 2004, PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells, Proc. Natl. Acad. Sci. USA., 101, 10691, 10.1073/pnas.0307252101
Lázár-Molnár, 2008, Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2, Proc. Natl. Acad. Sci. USA., 105, 10483, 10.1073/pnas.0804453105
Liang, 2003, Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses, Eur. J. Immunol., 33, 2706, 10.1002/eji.200324228
Lin, 2008, The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors, Proc. Natl. Acad. Sci. USA., 105, 3011, 10.1073/pnas.0712278105
Lobley, 2009, pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination, Bioinformatics., 25, 1761, 10.1093/bioinformatics/btp302
Lutz, 1999, An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow, J. Immunol. Methods., 223, 77, 10.1016/S0022-1759(98)00204-X
Mackey, 1997, Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154, Cancer Res., 57, 2569
McIvor, 1990, Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells, Nucleic Acids Res., 18, 7025, 10.1093/nar/18.23.7025
Nishimura, 1999, Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor, Immunity., 11, 141, 10.1016/S1074-7613(00)80089-8
Nishimura, 2001, Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice, Science., 291, 319, 10.1126/science.291.5502.319
Okazaki, 2006, The PD-1-PD-L pathway in immunological tolerance, Trends Immunol., 27, 195, 10.1016/j.it.2006.02.001
Rai, 2006, Multiple mapping method: a novel approach to the sequence-to-structure alignment problem in comparative protein structure modeling, Proteins., 63, 644, 10.1002/prot.20835
Rai, 2006, MMM: a sequence-to-structure alignment protocol, Bioinformatics., 22, 2691, 10.1093/bioinformatics/btl449
Salama, 2003, Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis, J. Exp. Med., 198, 71, 10.1084/jem.20022119
Shannon, 2003, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res., 13, 2498, 10.1101/gr.1239303
Shulman, 1978, A better cell line for making hybridomas secreting specific antibodies, Nature., 276, 269, 10.1038/276269a0
Sica, 2003, B7-H4, a molecule of the B7 family, negatively regulates T cell immunity, Immunity., 18, 849, 10.1016/S1074-7613(03)00152-3
Son, 2002, A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells, J. Immunol. Methods., 262, 145, 10.1016/S0022-1759(02)00013-3
Stromnes, 2006, Active induction of experimental allergic encephalomyelitis, Nat. Protoc., 1, 1810, 10.1038/nprot.2006.285
Stromnes, 2006, Passive induction of experimental allergic encephalomyelitis, Nat. Protoc., 1, 1952, 10.1038/nprot.2006.284
Su, 2002, Large-scale analysis of the human and mouse transcriptomes, Proc. Natl. Acad. Sci. USA., 99, 4465, 10.1073/pnas.012025199
Tivol, 1995, Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4, Immunity., 3, 541, 10.1016/1074-7613(95)90125-6
van Raaij, 2000, Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution, Structure., 8, 1147, 10.1016/S0969-2126(00)00528-1
Wang, 2008, Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells, Proc. Natl. Acad. Sci. USA., 105, 9331, 10.1073/pnas.0710441105
Waterhouse, 1995, Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4, Science., 270, 985, 10.1126/science.270.5238.985
Yamazaki, 2002, Expression of programmed death 1 ligands by murine T cells and APC, J. Immunol., 169, 5538, 10.4049/jimmunol.169.10.5538
Zhang, 1998, Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia, Blood., 92, 3829, 10.1182/blood.V92.10.3829.422k14_3829_3840